收费全文 | 5958篇 |
免费 | 438篇 |
国内免费 | 10篇 |
耳鼻咽喉 | 59篇 |
儿科学 | 179篇 |
妇产科学 | 192篇 |
基础医学 | 667篇 |
口腔科学 | 145篇 |
临床医学 | 799篇 |
内科学 | 863篇 |
皮肤病学 | 126篇 |
神经病学 | 599篇 |
特种医学 | 152篇 |
外科学 | 784篇 |
综合类 | 161篇 |
一般理论 | 4篇 |
预防医学 | 870篇 |
眼科学 | 48篇 |
药学 | 359篇 |
中国医学 | 7篇 |
肿瘤学 | 392篇 |
2023年 | 51篇 |
2022年 | 82篇 |
2021年 | 151篇 |
2020年 | 79篇 |
2019年 | 143篇 |
2018年 | 163篇 |
2017年 | 127篇 |
2016年 | 153篇 |
2015年 | 128篇 |
2014年 | 177篇 |
2013年 | 254篇 |
2012年 | 360篇 |
2011年 | 414篇 |
2010年 | 214篇 |
2009年 | 194篇 |
2008年 | 299篇 |
2007年 | 334篇 |
2006年 | 329篇 |
2005年 | 342篇 |
2004年 | 322篇 |
2003年 | 325篇 |
2002年 | 287篇 |
2001年 | 103篇 |
2000年 | 90篇 |
1999年 | 73篇 |
1998年 | 50篇 |
1997年 | 53篇 |
1996年 | 38篇 |
1995年 | 27篇 |
1994年 | 29篇 |
1993年 | 22篇 |
1992年 | 50篇 |
1991年 | 55篇 |
1990年 | 49篇 |
1989年 | 36篇 |
1988年 | 44篇 |
1987年 | 48篇 |
1986年 | 47篇 |
1985年 | 51篇 |
1984年 | 30篇 |
1983年 | 29篇 |
1982年 | 25篇 |
1979年 | 30篇 |
1978年 | 27篇 |
1976年 | 23篇 |
1974年 | 26篇 |
1973年 | 21篇 |
1969年 | 27篇 |
1968年 | 24篇 |
1966年 | 31篇 |
Introduction/Hypothesis
Recruitment of participants into phase 1 vaccine clinical trials can be challenging since these vaccines have not been used in humans and there is no perceived benefit to the participant. Occasionally, as was the case with a phase 1 clinical trial of an Ebola vaccine in Halifax, Canada, during the 2014–2016 West African Ebola virus outbreak, recruitment is less difficult. In this study, we explored the motivations of participants in two phase 1 vaccine trials that were concurrently enrolling at the same centre and compared the motivations of participants in a high-profile phase 1 Ebola vaccine trial to those in a less high-profile phase 1 adjuvanted seasonal influenza vaccine study.Methods
An online survey which included participants’ prior experience with clinical trials, motivations to participate (including financial incentives), and demographic information was developed to examine the motivations of healthy participants in two phase 1 clinical vaccine trials conducted at the Canadian Center for Vaccinology in Halifax, Nova Scotia. Participants were invited via email to complete the online survey. Readability and clarity were assessed through pilot testing.Results
A total of 49 (55.7%) of 88 participants of the two studies completed the survey (22 [55%] of 40 participants from the Ebola vaccine study and 27 [56.3%] of 48 from the adjuvanted influenza vaccine study). Motivations that were most frequently ranked among participants' top three in both trials were (1) wanting to contribute to the health of others, (2) wanting to participate in something important, (3) wanting to contribute to the advancement of science, and (4) wanting to receive an incentive such as money or a tablet.Conclusions/Recommendations
Although media attention and financial compensation were more often cited by Ebola vaccine trial participants as a reason to participate, both altruistic and self-interested factors were important motivations for participants in their decision to participate in a phase 1 vaccine clinical trial. 相似文献The metabolism of the pyrethroids deltamethrin (DLM), cis-permethrin (CPM) and trans-permethrin (TPM) was studied in human expressed cytochrome P450 (CYP) and carboxylesterase (CES) enzymes.
DLM, CPM and TPM were metabolised by human CYP2B6 and CYP2C19, with the highest apparent intrinsic clearance (CLint) values for pyrethroid metabolism being observed with CYP2C19. Other CYP enzymes contributing to the metabolism of one or more of the three pyrethroids were CYP1A2, CYP2C8, CYP2C9*1, CYP2D6*1, CYP3A4 and CYP3A5. None of the pyrethroids were metabolised by CYP2A6, CYP2E1, CYP3A7 or CYP4A11.
DLM, CPM and TPM were metabolised by both human CES1 and CES2 enzymes.
Apparent CLint values for pyrethroid metabolism by CYP and CES enzymes were scaled to per gram of adult human liver using abundance values for microsomal CYP enzymes and for CES enzymes in liver microsomes and cytosol. TPM had the highest and CPM the lowest apparent CLint values for total metabolism (CYP and CES enzymes) per gram of adult human liver.
Due to their higher abundance, all three pyrethroids were extensively metabolised by CES enzymes in adult human liver, with CYP enzymes only accounting for 2%, 10% and 1% of total metabolism for DLM, CPM and TPM, respectively.